Hib/MenC vaccine

The Hib/MenC vaccine helped protect against:

haemophilus influenzae type b (Hib)
meningococcal group C infection

However, the manufacturer of the Hib/MenC vaccine has now stopped making it.

Replacement for the Hib/MenC vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that young children no longer need to be offered a vaccine for meningococcal group C infection. This is because the meningococcal ACWY vaccine, offered to young people around age 14, has been successful in controlling the spread of meningococcal group C bacteria.

The meningococcal ACWY vaccine will still be offered to your child around age 14. It remains important for them to get the vaccine when offered.

The JCVI have advised that young children should still be offered protection against Hib infection. Children who are not offered the Hib/MenC vaccine will instead be offered a fourth dose of the 6-in-1 vaccine.

When your child will be offered a vaccine

Depending on when they’re born, your child will be offered either the Hib/MenC vaccine or an additional dose of the 6-in-1 vaccine.

If your child was born on or after 1 July 2024

Children who were born on or after 1 July 2024 will be offered a fourth dose of the 6-in-1 vaccine. This will be offered at a new 18 month vaccination appointment. These appointments will start from 1 January 2026.

If your child was born on or before 30 June 2024

Children born on or before 30 June 2024 will be offered the Hib/MenC vaccine when they are between 12 and 13 months old. This will only be for as long as the vaccine is available.

If there’s no Hib/MenC vaccine available, your child will be offered a fourth dose of the 6-in-1 vaccine instead.